Bertino JR - Search Results

1

Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines.

Li WW, Lin JT, Schweitzer BI, Tong WP, Niedzwiecki D, Bertino JR. Li WW, et al. Among authors: bertino jr. Cancer Res. 1992 Jul 15;52(14):3908-13. Cancer Res. 1992. PMID: 1377601

2

Fas-mediated signaling enhances sensitivity of human soft tissue sarcoma cells to anticancer drugs by activation of p38 kinase.

Li W, Bertino JR. Li W, et al. Among authors: bertino jr. Mol Cancer Ther. 2002 Dec;1(14):1343-8. Mol Cancer Ther. 2002. PMID: 12516968

3

p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53.

Magro PG, Russo AJ, Li WW, Banerjee D, Bertino JR. Magro PG, et al. Among authors: bertino jr. Cancer Res. 2004 Jun 15;64(12):4338-45. doi: 10.1158/0008-5472.CAN-03-1045. Cancer Res. 2004. PMID: 15205349

4

The basis for intrinsic drug resistance or sensitivity to methotrexate.

Bertino JR, Lin J, Pizzorno G, Li WW, Chang YM. Bertino JR, et al. Adv Enzyme Regul. 1989;29:277-85. doi: 10.1016/0065-2571(89)90107-6. Adv Enzyme Regul. 1989. PMID: 2633614

5

Increased activity of gamma-glutamyl hydrolase in human sarcoma cell lines: a novel mechanism of intrinsic resistance to methotrexate (MTX).

Li WW, Waltham M, Tong W, Schweitzer BI, Bertino JR. Li WW, et al. Among authors: bertino jr. Adv Exp Med Biol. 1993;338:635-8. doi: 10.1007/978-1-4615-2960-6_131. Adv Exp Med Biol. 1993. PMID: 7508171 No abstract available.

6

Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase.

Zhao SC, Li MX, Banerjee D, Schweitzer BI, Mineishi S, Gilboa E, Bertino JR. Zhao SC, et al. Among authors: bertino jr. Cancer Gene Ther. 1994 Mar;1(1):27-33. Cancer Gene Ther. 1994. PMID: 7621235

7

Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease.

Göker E, Lin JT, Trippett T, Elisseyeff Y, Tong WP, Niedzwiecki D, Tan C, Steinherz P, Schweitzer BI, Bertino JR. Göker E, et al. Among authors: bertino jr. Leukemia. 1993 Jul;7(7):1000-4. Leukemia. 1993. PMID: 7686600

8

Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates.

Barakat RR, Li WW, Lovelace C, Bertino JR. Barakat RR, et al. Among authors: bertino jr. Gynecol Oncol. 1993 Oct;51(1):54-60. doi: 10.1006/gyno.1993.1246. Gynecol Oncol. 1993. PMID: 7694891

9

A phase II study of continuous infusion of trimetrexate in patients with refractory acute leukemia.

Kheradpour A, Berman E, Göker E, Lin JT, Tong WP, Bertino JR. Kheradpour A, et al. Among authors: bertino jr. Cancer Invest. 1995;13(1):36-40. doi: 10.3109/07357909509024893. Cancer Invest. 1995. PMID: 7834472 Clinical Trial.

10

Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.

Fanin R, Banerjee D, Volkenandt M, Waltham M, Li WW, Dicker AP, Schweitzer BI, Bertino JR. Fanin R, et al. Among authors: bertino jr. Mol Pharmacol. 1993 Jul;44(1):13-21. Mol Pharmacol. 1993. PMID: 8341268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

711 results

Search Page

Filters